MEGAN MILLIKAN: Open Payments
NPI 1811389737 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 103 payments from 33 companies in 2025. Trend: 2023 $1,777 · 2024 $2,295 · 2025 $2,173
Food & beverage: $2,173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $292 |
| UCB, Inc. | 9 | $249 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $190 |
| Biogen, Inc. | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| PFIZER INC. | 5 | $85 |
| Axsome Therapeutics, Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Lilly USA, LLC | 4 | $74 |
| ARGENX US, INC. | 4 | $63 |
Products named: LUMRYZ, QULIPTA, Leqembi, HYQVIA, Rystiggo, Fintepla, NURTEC ODT, REXULTI.
Industry payments across NC — which companies pay providers there.
